The influence of the signal dynamics of activated form of IKK on NF‐κB and anti‐apoptotic gene expressions: A systems biology approach

NF‐κB activation plays a crucial role in anti‐apoptotic responses in response to the apoptotic signaling during tumor necrosis factor (TNF)‐α stimulation. TNF‐α induces apoptosis sensitive to the hepatitis B virus (HBV) infected cells, despite sustained NF‐κB activation. Our results indicate that the HBV infection induces sustained NF‐κB activation, in a manner similar to the TNF‐α stimulation. However, these effects are not merely combined. Computational simulations show that the level of form of the IKK complex activated by phosphorylation (IKK‐p) affects the dynamic pattern of NF‐κB activation during TNF‐α stimulation in the following ways: (i) the initial level of IKK‐p determines the incremental change in IKK‐p at the same level of TNF‐α stimulation, (ii) the incremental change in IKK‐p determines the amplitudes of active NF‐κB oscillation, and (iii) the steady state level of IKK‐p after the incremental change determines the period of active NF‐κB oscillation. Based on experiments, we observed that the initial level of IKK‐p was upregulated and the active NF‐κB oscillation showed smaller amplitudes for a shorter period in HepG2.2.15 cells (HBV‐producing cells) during TNF‐α stimulation, as was indicated by the computational simulations. Furthermore, we found that during TNF‐α stimulation, NF‐κB‐regulated anti‐apoptotic genes were upregulated in HepG2 cells but were downregulated in HepG2.2.15 cells. Based on the previously mentioned results, we can conclude that the IKK‐p‐level changes induced by HBV infection modulate the dynamic pattern of active NF‐κB and thereby could affect NF‐κB‐regulated anti‐apoptotic gene expressions. Finally, we postulate that the sensitive apoptotic response of HBV‐infected cells to TNF‐α stimulation is governed by the dynamic patterns of active NF‐κB based on IKK‐p level changes.

[1]  W. Walters,et al.  TNAP, a Novel Repressor of NF-κB-inducing Kinase, Suppresses NF-κB Activation* , 2004, Journal of Biological Chemistry.

[2]  Kwang-Hyun Cho,et al.  The dynamic systems approach to control and regulation of intracellular networks , 2005, FEBS letters.

[3]  U. Bhalla Signaling in small subcellular volumes. II. Stochastic and diffusion effects on synaptic network properties. , 2004, Biophysical journal.

[4]  F. Su,et al.  Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Lauffenburger Cell signaling pathways as control modules: complexity for simplicity? , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Baldwin Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. , 2001, The Journal of clinical investigation.

[7]  Michael Karin,et al.  Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation , 1999 .

[8]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[9]  R. Dziarski,et al.  Micrococci and Peptidoglycan Activate TLR2→MyD88→IRAK→TRAF→NIK→IKK→NF-κB Signal Transduction Pathway That Induces Transcription of Interleukin-8 , 2001, Infection and Immunity.

[10]  Michael Karin,et al.  NF-κB in cancer: a marked target , 2003 .

[11]  Jesper Tegnér,et al.  Systems biology is taking off. , 2003, Genome research.

[12]  Kwang-Hyun Cho,et al.  Experimental Design in Systems Biology, Based on Parameter Sensitivity Analysis Using a Monte Carlo Method: A Case Study for the TNFα-Mediated NF-κ B Signal Transduction Pathway , 2003, Simul..

[13]  R. Eils,et al.  Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis , 2004, The Journal of cell biology.

[14]  T. Gilmore Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel , 1999, Oncogene.

[15]  C. Amici,et al.  NEW EMBO MEMBER’S REVIEW: NF-κB and virus infection: who controls whom , 2003 .

[16]  P. Ramakrishnan,et al.  Receptor-Specific Signaling for Both the Alternative and the Canonical NF-κB Activation Pathways by NF-κB-Inducing Kinase , 2004 .

[17]  D. Lauffenburger,et al.  A Computational Study of Feedback Effects on Signal Dynamics in a Mitogen‐Activated Protein Kinase (MAPK) Pathway Model , 2001, Biotechnology progress.

[18]  Chi-Ying F. Huang,et al.  Ultrasensitivity in the mitogen-activated protein kinase cascade. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Hopfield,et al.  From molecular to modular cell biology , 1999, Nature.

[20]  C. Gélinas,et al.  To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis , 2003, Oncogene.

[21]  C. Seeger,et al.  Hepatitis B Virus Biology , 2000, Microbiology and Molecular Biology Reviews.

[22]  Eduardo Sontag,et al.  Untangling the wires: A strategy to trace functional interactions in signaling and gene networks , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  F. Su,et al.  Role of NF-κB and Myc Proteins in Apoptosis Induced by Hepatitis B Virus HBx Protein , 2001, Journal of Virology.

[24]  M. Feitelson Hepatitis B virus in hepatocarcinogenesis , 1999, Journal of cellular physiology.

[25]  P. Scheurich,et al.  The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Alexander Hoffmann,et al.  Stimulus Specificity of Gene Expression Programs Determined by Temporal Control of IKK Activity , 2005, Science.

[27]  Zongyi Hu,et al.  Additive activation of hepatic NF‐κB by ethanol and hepatitis B protein X (HBX) or HCV core protein: involvement of TNF‐α receptor 1‐independent and ‐dependent mechanisms , 2001 .

[28]  S. Murakami Hepatitis B virus X protein: a multifunctional viral regulator , 2001, Journal of Gastroenterology.

[29]  A. Zuckerman More than third of world's population has been infected with hepatitis B virus , 1999, BMJ.

[30]  Anand R Asthagiri,et al.  Resistance to signal activation governs design features of the MAP kinase signaling module , 2004, Biotechnology and bioengineering.

[31]  Marek Kimmel,et al.  Mathematical model of NF- κB regulatory module , 2004 .

[32]  G. Acs,et al.  Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Wei‐Chien Huang,et al.  Tyrosine Phosphorylation of I-κB Kinase α/β by Protein Kinase C-Dependent c-Src Activation Is Involved in TNF-α-Induced Cyclooxygenase-2 Expression1 , 2003, The Journal of Immunology.

[34]  H. Koh,et al.  Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  Kwang-Hyun Cho,et al.  Investigations Into the Analysis and Modeling of the TNFα-Mediated NF-κB-Signaling Pathway , 2003 .

[36]  M. Karin,et al.  The two NF-κB activation pathways and their role in innate and adaptive immunity , 2004 .

[37]  Sun Park,et al.  NF-kappaB activation by hepatitis B virus X (HBx) protein shifts the cellular fate toward survival. , 2002, Cancer letters.

[38]  Soon B. Hwang,et al.  Interferon-γ Inhibits Hepatitis B Virus–Induced NF-κB Activation Through Nuclear Localization of NF-κB–Inducing Kinase , 2005 .

[39]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.